Andrew Spaventa - Nov 12, 2024 Form 4 Insider Report for Singular Genomics Systems, Inc. (OMIC)

Role
Chief Executive Officer, Director
Signature
/s/ Dalen Meeter, Attorney-in-Fact
Stock symbol
OMIC
Transactions as of
Nov 12, 2024
Transactions value $
-$15,669
Form type
4
Date filed
11/13/2024, 04:43 PM
Previous filing
Sep 17, 2024
Next filing
Dec 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OMIC Common Stock Options Exercise +1.91K +586.77% 2.23K Nov 12, 2024 Direct F1
transaction OMIC Common Stock Sale -$15.7K -695 -31.14% $22.55 1.54K Nov 12, 2024 Direct F2
transaction OMIC Common Stock Gift $0 -1.21K -78.85% $0.00 325 Nov 12, 2024 Direct F3
transaction OMIC Common Stock Gift $0 +1.21K +0.86% $0.00 141K Nov 12, 2024 By The Andrew K. Spaventa Living Trust dated April 9, 2014 F3
holding OMIC Common Stock 85 Nov 12, 2024 By Axon Holdings, LLC F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMIC Restricted Stock Units Options Exercise $0 -1.91K -7.15% $0.00 24.8K Nov 12, 2024 Common Stock 1.91K Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F2 The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted RSUs.
F3 Immediately upon settlement of the vested RSUs, and following the withholding described above, the Reporting Person transferred the shares as a gift to The Andrew K. Spaventa Living Trust dated April 9, 2014.
F4 The shares are held directly by Axon Holdings, LLC. The managing member of Axon Holdings, LLC is Axon Managers, LLC. The Reporting Person is a managing member of Axon Managers, LLC and may be deemed to have shared voting and investment power over the shares held by Axon Holdings, LLC. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
F5 Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F6 The RSUs vest in 16 equal quarterly installments over four years measured from February 12, 2024.